Amicus Therapeutics, Inc.
US ˙ NasdaqGM ˙ US03152W1099
DETTE SYMBOL ER IKKE LÆNGERE AKTIVT

SecurityFOLD / Amicus Therapeutics, Inc.
InstitutionDeutsche Bank Ag\
Latest Disclosed Ownership282,792 shares
Latest Disclosed Value $ 4,089,172
Deutsche Bank Ag\ ownership in FOLD / Amicus Therapeutics, Inc.

On May 6, 2026 - Deutsche Bank Ag\ filed a 13F-HR form disclosing ownership of 282,792 shares of Amicus Therapeutics, Inc. (US:FOLD) valued at $4,089,172 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 3,457,228 shares of Amicus Therapeutics, Inc.. This represents a change in shares of -91.82% during the quarter. The current value of the position is $4,097,656 USD.

Deutsche Bank Ag\ has a history of taking positions in derivatives of the underlying security (FOLD) in the form of stock options.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

FOLD / Amicus Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-06 2026-03-31 13F AMICUS THERAPEUTIC COM 03152W109 282,792 -3,174,436 -91.82 4,089 -91.69 0.0003
2026-02-11 2025-12-31 13F AMICUS THERAPEUTICS COM 03152W109 3,457,228 976,630 39.37 49,231 151.85 0.0160
2025-11-13 2025-09-30 13F AMICUS THERAPEUTICS COM 03152W109 2,480,598 1,213,295 95.74 19,547 169.21 0.0065
2025-08-12 2025-06-30 13F AMICUS THERAPEUTICS COM 03152W109 1,267,303 228,313 21.97 7,262 -14.35 0.0027
2025-05-09 2025-03-31 13F AMICUS THERAPEUTICS COM 03152W109 1,038,990 216,882 26.38 8,478 9.48 0.0034
2025-06-30 2024-12-31 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 822,108 87,491 11.91 7,744 -1.29 0.0030
2025-02-14 2024-12-31 13F AMICUS THERAPEUTICS COM 03152W109 822,108 87,491 7,744 0.0030
2025-06-26 2024-09-30 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 734,617 -2,254,799 -75.43 7,846 -73.55 0.0032
2024-11-13 2024-09-30 13F AMICUS THERAPEUTICS COM 03152W109 734,617 -2,254,799 7,846 0.0032
2025-06-12 2024-06-30 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 2,989,416 -1,361,665 -31.29 29,655 -42.14 0.0134
2024-08-14 2024-06-30 13F AMICUS THERAPEUTICS COM 03152W109 2,989,416 -1,361,665 29,655 0.0134
2025-06-02 2024-03-31 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 4,351,081 -1,427,663 -24.71 51,256 -37.49 0.0238
2024-05-15 2024-03-31 13F AMICUS THERAPEUTICS COM 03152W109 4,351,081 -1,427,663 51,256 0.0238
2024-02-14 2023-12-31 13F AMICUS THERAPEUTICS COM 03152W109 5,778,744 5,632,116 3,841.09 82,000 4,501.57 0.0418
2023-11-24 2023-09-30 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 146,628 -6,112,106 -97.66 1,783 -97.73 0.0012
2023-11-09 2023-09-30 13F AMICUS THERAPEUTICS COM 03152W109 146,628 -6,112,106 1,783 0.0002
2023-08-14 2023-06-30 13F AMICUS THERAPEUTICS COM 03152W109 6,258,734 5,151,461 465.24 78,610 540.19 0.0418
2023-05-15 2023-03-31 13F AMICUS THERAPEUTICS COM 03152W109 1,107,273 70,969 6.85 12,280 -2.96 0.0068
2023-02-13 2022-12-31 13F AMICUS THERAPEUTICS COM 03152W109 1,036,304 -523,256 -33.55 12,653 -22.29 0.0073
2022-11-14 2022-09-30 13F AMICUS THERAPEUTICS COM 03152W109 1,559,560 -4,731,916 -75.21 16,282 -75.90 0.0098
2022-08-11 2022-06-30 13F AMICUS THERAPEUTICS COM 03152W109 6,291,476 641,299 11.35 67,571 26.28 0.0377
2022-05-13 2022-03-31 13F AMICUS THERAPEUTICS COM 03152W109 5,650,177 -118,470 -2.05 53,508 -19.69 0.0250
2022-02-16 2021-12-31 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 5,768,647 -1,348,747 -18.95 66,627 -1.98 0.0300
2022-02-11 2021-12-31 13F AMICUS THERAPEUTICS COM 03152W109 5,768,647 -1,348,747 66,627 0.0033
2021-11-04 2021-09-30 13F AMICUS THERAPEUTICS COM 03152W109 7,117,394 -1,227,336 -14.71 67,971 -15.50 0.0322
2021-08-11 2021-06-30 13F AMICUS THERAPEUTICS COM 03152W109 8,344,730 1,030,803 14.09 80,443 11.32 0.0391
2021-05-13 2021-03-31 13F AMICUS THERAPEUTICS COM 03152W109 7,313,927 1,800,313 32.65 72,261 -43.24 0.0389
2021-02-16 2020-12-31 13F AMICUS THERAPEUTICS COM 03152W109 5,513,614 -491,838 -8.19 127,309 50.14 0.0777
2020-11-12 2020-09-30 13F AMICUS THERAPEUTICS COM 03152W109 6,005,452 -255,357 -4.08 84,796 -10.19 0.0583
2020-08-13 2020-06-30 13F AMICUS THERAPEUTICS COM 03152W109 6,260,809 2,139,554 51.92 94,413 147.93 0.0718
2020-05-14 2020-03-31 13F AMICUS THERAPEUTICS COM 03152W109 4,121,255 2,492,623 153.05 38,080 140.10 0.0340
2020-02-14 2019-12-31 13F AMICUS THERAPEUTICS COM 03152W109 1,628,632 -4,007,053 -71.10 15,860 -64.91 0.0103
2019-11-14 2019-09-30 13F AMICUS THERAPEUTICS COM 03152W109 5,635,685 -86,760 -1.52 45,195 -36.71 0.0314
2019-08-14 2019-06-30 13F AMICUS THERAPEUTICS COM 03152W109 5,722,445 3,205,378 127.35 71,413 108.64 0.0419
2019-05-15 2019-03-31 13F AMICUS THERAPEUTICS COM 03152W109 2,517,067 381,835 17.88 34,228 67.36 0.0204
2019-04-01 2018-12-31 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 2,135,232 -431,480 -16.81 20,452 -34.09 0.0145
2019-02-14 2018-12-31 13F AMICUS THERAPEUTICS COM 03152W109 2,135,232 272,405 20,452
2021-12-21 2018-09-30 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 2,566,712 588,522 29.75 31,031 0.43 0.0157
2018-11-14 2018-09-30 13F AMICUS THERAPEUTICS COM 03152W109 1,862,827 -115,363 22,520 0.0156
2020-04-21 2018-06-30 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 1,978,190 -841,204 -29.84 30,899 -27.12 0.0154
2018-08-14 2018-06-30 13F AMICUS THERAPEUTICS COM 03152W109 1,658,301 -1,161,093 25,900 17,202.7155
2019-10-23 2018-03-31 13F/A-2 AMICUS THERAPEUTICS COM 03152W109 2,819,394 844,274 42.75 42,399 49.19 0.0202
2019-10-18 2018-03-31 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 2,819,394 0 42,399 0.0202
2018-05-15 2018-03-31 13F AMICUS THERAPEUTICS COM 03152W109 2,371,771 396,651 35,668
2018-02-14 2017-12-31 13F AMICUS THERAPEUTICS COM 03152W109 1,975,120 -341,668 -14.75 28,420 -18.65 0.0182
2017-11-14 2017-09-30 13F AMICUS THERAPEUTICS COM 03152W109 2,316,788 1,341,181 137.47 34,935 255.68 0.0239
2017-08-11 2017-06-30 13F AMICUS THERAPEUTICS COM 03152W109 975,607 -75,111 -7.15 9,822 31.17 0.0070
2017-05-15 2017-03-31 13F AMICUS THERAPEUTICS COM 03152W109 1,050,718 -74,305 -6.60 7,488 34.00 0.0055
2017-02-14 2016-12-31 13F AMICUS THERAPEUTICS COM 03152W109 1,125,023 -229,804 -16.96 5,588 -44.25 0.0045
2016-11-14 2016-09-30 13F AMICUS THERAPEUTICS COM 03152W109 1,354,827 497,199 57.97 10,023 114.17 0.0071
2016-08-15 2016-06-30 13F AMICUS THERAPEUTICS COM 03152W109 857,628 530,201 161.93 4,680 69.20 0.0033
2016-05-16 2016-03-31 13F AMICUS THERAPEUTICS COM 03152W109 327,427 -441,825 -57.44 2,766 -62.92 0.0021
2016-02-16 2015-12-31 13F AMICUS THERAPEUTICS COM 03152W109 769,252 224,754 41.28 7,459 -2.05 0.0052
2015-11-17 2015-09-30 13F AMICUS THERAPEUTICS COM 03152W109 544,498 257,730 89.87 7,615 87.75 0.0059
2015-08-12 2015-06-30 13F AMICUS THERAPEUTICS COM 03152W109 286,768 -158,379 -35.58 4,056 -16.22 0.0026
2015-05-15 2015-03-31 13F AMICUS THERAPEUTICS COM 03152W109 445,147 72,976 19.61 4,841 56.41 0.0030
2015-02-13 2014-12-31 13F AMICUS THERAPEUTICS COM 03152W109 372,171 186,513 100.46 3,095 180.60 0.0019
2014-11-14 2014-09-30 13F AMICUS THERAPEUTICS COM 03152W109 185,658 39,443 26.98 1,103 126.49 0.0007
2014-08-15 2014-06-30 13F AMICUS THERAPEUTICS COM 03152W109 146,215 126,567 644.17 487 1,117.50 0.0003
2014-05-15 2014-03-31 13F AMICUS THERAPEUTICS COM 03152W109 19,648 13,704 230.55 40 207.69 0.0000
2014-02-24 2013-12-31 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 5,944 -87,198 -93.62 13 -93.95 0.0000
2014-02-18 2013-12-31 13F AMICUS THERAPEUTICS COM 03152W109 5,944 13
2013-11-18 2013-09-30 13F AMICUS THERAPEUTICS COM 03152W109 93,142 93,142 215 0.0002
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2015-11-17 2015-09-30 13F AMICUS THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2015-08-12 2015-06-30 13F AMICUS THERAPEUTICS COM Put 500 7 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.